Skip to main navigation

Home
Technology
- Product Details
- HIFU Technology
Physicians
- Prostate Cancer Management
- Clinical Information
Patients
Company

Menu

Home
Technology
- Product Details
- HIFU Technology
Physicians
- Prostate Cancer Management
- Clinical Information
Patients
Company

FocalTherics™ - Investor Relations

Events & Presentations

Investor Relations

Overview
News & Events
- News
- Events & Presentations
Financial Information
Stock Information
Corporate Governance
Investor Resources
- Contact Us
- Email Alerts

Conference & Events

More events are coming soon.

IR Corporate Presentation

More information is coming soon.

Archived Events

EDAP to Present at Jefferies Global Healthcare Conference in New York

Jun 4, 2026 AT 2:00 PM EDT

Listen to webcast

Focal One Investor Day

Jun 1, 2026 AT 8:00 AM EDT

Listen to webcast

Download Presentation 8.7 MB

EDAP TMS First Quarter 2026 Earnings Conference Call

May 7, 2026 AT 8:30 AM EDT

Listen to webcast

EDAP TMS Fourth Quarter 2025 Earnings Conference Call

Mar 25, 2026 AT 8:30 AM EDT

Listen to webcast

EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 18, 2026 AT 12:00 PM EDT

Listen to webcast

EDAP to Present at Jefferies Global Healthcare Conference in London

Nov 18, 2025 AT 4:30 PM GMT

Listen to webcast

EDAP to Participate in the UBS Global Healthcare Conference

Nov 10, 2025

Listen to webcast

EDAP TMS Third Quarter 2025 Earnings Conference Call

Nov 6, 2025 AT 8:30 AM EST

Listen to webcast

EDAP to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Sep 9, 2025 AT 8:30 AM EDT

Listen to webcast

EDAP TMS Second Quarter 2025 Earnings Conference Call

Aug 28, 2025 AT 8:30 AM EDT

Listen to webcast

Investor Contact

Louisa Smith

Gilmartin Group

investor.relations@focalone.com

EDAP TMS SA

investor.relations@focalone.com

Get Updates And Stay Connected

Get New Updates Directly To Your Inbox.

Email Address* Required

Focal One® - HIFU Prostate Tissue Ablation

Focal One^® has received regulatory clearance and is marketed in the United States, Europe, Canada, Korea, Russia, Brazil and other countries. In the United States, Focal One^® is indicated for the ablation of prostate tissue. Focal One^® is a registered trademark of EDAP TMS.

Discover More

FocalTherics Information

P: +1(512) 832-7956
E: investor.relations@focalone.com
A: 4410 El Camino Real, # 150,
Los Altos, CA 94022

EDAP TMS S.A., the issuer of record for the Company's publicly traded securities, is evolving its corporate brand to FocalTherics to better reflect its focused therapeutic ultrasound strategy and long-term growth vision. While the Company will continue to operate under its legal name, EDAP TMS S.A., it now does business as FocalTherics across its investor and corporate communications. This brand transition aligns the Company's identity with its expanding innovation portfolio while maintaining continuity, transparency, and regulatory compliance for shareholders. All historical filings, disclosures, and governance materials remain attributable to EDAP TMS S.A., ensuring clarity and consistency throughout this evolution.